Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Mountain range with trees and river
Sustainability

Quotient Sciences 2023 ESG Report

10 December 2024 Download

141 - 150 of 221 results

Scientific Poster, First-in-Human
ASCPT 2016: A randomised double-blind dose escalation study to evaluate the safety and dose response of subcutaneous administration of coversin in healthy subjects
26 October 2017
Download Now
Scientific Poster, First-in-Human
AACR 2016 Poster: Clinical Pharmacokinetics and Pharmacodynamics of ME-401
26 October 2017
Download Now
Scientific Poster, Formulation Development, Clinical Pharmacology
AAPS 2015 Poster: Rapid Formulation Development and Clinical Testing of Gastro-Retentive Controlled Release Technology to Enable Once-Daily Dosing
26 October 2017
Download Now
Scientific Poster, Human ADME, First-in-Human, Clinical Pharmacology
DMDG 2016 Poster: A Phase I, open-label, 2-Part study to establish absolute bioavailability
26 October 2017
Download Now
Scientific Poster, Human ADME, Oncology
ISSX 2014 Poster: Flexible strategies for the conduct of human metabolism studies with oncology molecules
26 October 2017
Download Now
Scientific Poster, Human ADME, Oncology
AAPS 2015 Poster: Conduct of clinical ADME study for Vosaroxin in oncology patients
26 October 2017
Download Now
Scientific Poster, Pediatrics, Translational Pharmaceutics, Oncology
ISSX Poster: An Open-label, Two-period Study Designed to Evaluate and Compare the Mass Balance Recovery and Metabolite Profile of 14C-Deutetrabenazine and 14C-Tetrabenazine in Healthy Male Subjects
26 June 2017
Download Now
Case Study, First-in-Human, Clinical Trial Manufacturing, Commercial Manufacturing
Case Study: Corcept Therapeutics
Download Now
Case Study, Flow Chemistry, Drug Substance
Case Study: Thermal Rearrangement - Flow Chemistry
Download Now
Case Study, Drug Substance, API Development
Case Study: API Development
Download Now
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk